EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Nanalysis Scientific Corp (NSCIF) fair value: what the stock is really worth

As of Sep 28, 2026: fair value of Nanalysis Scientific Corp $0.23, price $0.08, upside +184.0%, quality 35 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Technology · US · ISIN CA63000Y1034

NS Nanalysis Scientific Corp logo Thin data Sep 24, 2026

Nanalysis Scientific Corp

NSCIF · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value $0.2320 · Strongly undervalued (+184.0%)
!Quality 35/100
!Mixed Growth (revenue 5y +38.5 %/yr)
!Loss-making · -14.0% net margin (TTM)
✓Low debt · generates free cash flow
!Narrow moat 8/100
!Evidence only low, so the estimate is less certain
Watch Nanalysis Scientific Corp for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$1.33 $0.0817 Fair Value $0.2320 May 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range $0.0817 – $1.33 · fair‑value band $0.1816 – $0.3077 · the $0.0817 price screens below the $0.2320 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment.

Show more

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; a 60-NMR platform; 100-NMR platform; 60-TEACH; QUAD NMR Console; and the Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, a user interface for data acquisition and processing of benchtop NMR products; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security services, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, education, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. Nanalysis Scientific Corp. is headquartered in Calgary, Canada.

Stock analysis

Nanalysis Scientific Corp (NSCIF) currently trades at $0.0817, while our model-based Fair Value estimate is $0.2320, implying the stock looks roughly 64.8% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $0.2400 per share, and 5 of the 7 models we run sit above the $0.0817 price.

Bear case: the Asset-Based group reads lowest at $0.0500, and 2 of the 7 models stay below the price. Evidence for this calculation is low.

Scenario range: $0.1816 (bear) to $0.3077 (bull), the price of $0.0817 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 35/100 (below-average quality), in the Technology sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Nanalysis Scientific Corp reported revenue of C$40.1M in FY2025 versus C$16.0M in FY2021, a compound +25.8%/yr. Reported net income was −C$5.7M in FY2025.

Key figures

Market cap $11.5M · P/S ratio 0.29 · EPS (TTM) $−0.0400 · Net margin −14.1% · Return on equity −41.4% · Return on assets (EBIT) −12.1% · Operating margin −8.2% · Revenue (TTM) C$40.2M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).

What moves the price

The share trades about 47% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −37% fair-value upside, at 184%, NSCIF screens cheaper than that median.

Fair Value models

Bear $0.1816 Fair Value $0.2320 Bull $0.3077
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $0.1800 $0.3000 $0.6600 75
Growth DCF $0.1700 $0.3300 $0.6400 74
5Y Revenue Exit $0.0900 $0.1600 $0.3000 69
All 7 models by family
DCF Models
FCF DCF $0.1800 $0.3000 $0.6600 75
5Y Revenue Exit $0.0900 $0.1600 $0.3000 69
10Y Revenue Exit $0.1100 $0.2400 $0.3200 66
Multiples
EV/Revenue $0.0400 $0.0700 $0.1100 51
Asset-Based
NCAV (Graham) $0.0300 $0.0500 $0.0700 53
Growth DCF
Growth DCF $0.1700 $0.3300 $0.6400 74
Rev-Margin DCF $0.0900 $0.1900 $0.3500 69

Open the full fair value analysis →

Notify me when NSCIF reaches fair value

Put NSCIF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 35/100

Of which business quality 36 · Market factors (momentum, volatility) 19

Profitability 25
Margins and returns on capital today
Quality Growth 31
Are margins and returns improving?
Cashflow 29
Earnings quality: real cash, not paper profit
Fin. Strength 23
Balance sheet, leverage, solvency risk
Investment 95
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 8
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 38
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 56/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−11.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+38.5%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−47.5% (2020) → −9.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+4.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in CAD, Canada: IMF forecast 2.1% a year to 2030, 2.6% from 2016 to 2025) that is about +2.6% a year for the price.

Watch NSCIF, get fair value alerts →

Compare Nanalysis Scientific Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 154 stocks

Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 35 · Bottom 25%
Fair Value upside −74.8% · Bottom 25%
Profitability
Return on assets −6.1% · Bottom 25%
Net margin (TTM) −14.0% · Bottom 25%
Operating margin (TTM) −8.2% · Bottom 25%
Growth and dividend
Revenue growth 0.7% · Below median
Balance sheet
Debt / equity 0.46× · Highest 25%

Valuation Multiplesvs Scientific & Technical Instruments median · lower = cheaper

P/B 0.86× · Cheapest 25%
P/S (TTM) 0.29× · Cheapest 25%
P/FCF 7.3× · Cheapest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Keysight Technologies, Inc KEYS $362.15 $116.07 −68%
Coherent Corp COHR $292.21 $98.35 −66%
Garmin Ltd GRMN $294.14 $304.44 +4%
Chroma ATE Inc 2360 2,295 TWD 614.66 TWD −73%
Teledyne Technologies Incorporated TDY $605.59 $666.15 +10%
AVIC Chengdu Aircraft Company 302132 ¥72.18 ¥19.61 −73%
MKS Inc MKSI $260.82 $199.90 −23%
Fortive Corporation FTV $56.09 $35.20 −37%
Trimble Inc TRMB $57.85 $29.24 −49%
Cognex Corporation CGNX $58.75 $38.10 −35%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nanalysis Scientific Corp · Fair Value
$0.2320 +65%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Nanalysis Scientific Corp Fair Value". https://www.fairvalue-calculator.com/stock/NSCIF

Frequently asked questions

Is Nanalysis Scientific Corp (NSCIF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.2320 versus a price of $0.0817, about +184% upside (undervalued).
What is the fair value of NSCIF?
Our model-based fair value for Nanalysis Scientific Corp is $0.2320 (as of Sep 24, 2026), built from audited fundamentals. The current price: $0.0817.
What is the quality score of NSCIF?
Nanalysis Scientific Corp has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nanalysis Scientific Corp (NSCIF)?
Our model-based price target is the fair value of $0.2320 (as of Sep 24, 2026) from 7 valuation models. Cautious scenario $0.1816, optimistic scenario $0.3077. It is a calculation from audited fundamentals, not an analyst target.
What is the Nanalysis Scientific Corp stock forecast for 2026?
Our models put fair value at $0.2320, about +184% upside versus a price of $0.0817 (undervalued). Cautious scenario $0.1816, optimistic scenario $0.3077. The calculation is refreshed regularly with new filings.
What is the revenue of Nanalysis Scientific Corp (NSCIF)?
Nanalysis Scientific Corp reported trailing-twelve-month revenue of about C$40.2M (latest available figure, as of Sep 24, 2026).
What growth is priced into Nanalysis Scientific Corp (NSCIF)?
For today's price to be fair in a discounted-cash-flow model, Nanalysis Scientific Corp would have to grow free cash flow by +4.8 % per year for five years (discount rate 8.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +38.5 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of NSCIF use?
Our models discount Nanalysis Scientific Corp at 8.5 %: a base by market capitalisation (nano), damped by beta 0.09, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nanalysis Scientific Corp that is +4.8 % per year a year over ten years, using the same discount rate (8.5 %) and the same formula as our fair value.
How much growth has Nanalysis Scientific Corp (NSCIF) delivered so far?
Over the past 5 years revenue at Nanalysis Scientific Corp grew +38.5 % a year. The price currently implies +4.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Nanalysis Scientific Corp (NSCIF) growing?
The median revenue growth in the sector is +10.3 % a year. That is the yardstick for the growth priced into Nanalysis Scientific Corp (+4.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nanalysis Scientific Corp (NSCIF)?
The free-cash-flow yield on the price is 11.73 %: that much free cash flow Nanalysis Scientific Corp produces per unit of market value. When it exceeds the discount rate of our models (8.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nanalysis Scientific Corp (NSCIF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nanalysis Scientific Corp it is $0.2320 per share (as of Sep 24, 2026), against a price of $0.0817. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Nanalysis Scientific Corp stock overvalued or undervalued in 2026?
As of Sep 24, 2026, NSCIF trades below its calculated fair value: price $0.0817, fair value $0.2320, a gap of about +184% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NSCIF?
No. The price is what the market pays today ($0.0817); the fair value is what the company's own numbers justify ($0.2320). For Nanalysis Scientific Corp the two are $0.1503 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nanalysis Scientific Corp worth?
The market values Nanalysis Scientific Corp at about $11.5M (market capitalisation, as of Sep 24, 2026). Per share that is $0.0817; our models calculate a fair value of $0.2320 per share.
What do the bullish and bearish scenarios say about NSCIF?
Our models span a range for Nanalysis Scientific Corp: cautious scenario $0.1816, base $0.2320, optimistic $0.3077 per share (as of Sep 24, 2026, price $0.0817). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nanalysis Scientific Corp (NSCIF)?
Balance-sheet figures for Nanalysis Scientific Corp (as of Sep 24, 2026): return on equity −41.4%, debt of 0.46 per unit of equity. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is NSCIF from its 52-week high?
Nanalysis Scientific Corp trades at $0.0817, about 47% below its 52-week high of $0.1544 and at the low of $0.0817 (as of Sep 28, 2026). Distance from the high says nothing about value: that is what the fair value of $0.2320 is for.
Which stocks are comparable to Nanalysis Scientific Corp?
From the same area (Technology) we also value Keysight Technologies, Inc, Coherent Corp, Garmin Ltd, Chroma ATE Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nanalysis Scientific Corp stock attractive at the current price?
The data as of Sep 24, 2026: price $0.0817, calculated fair value $0.2320 (+184%), Quality Score 35/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NSCIF calculated?
We run Nanalysis Scientific Corp through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.2320, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Nanalysis Scientific Corp currently trades 65 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nanalysis Scientific Corp (NSCIF)?
The closing price on Sep 28, 2026 was $0.0817. Our model-based fair value is $0.2320, about +184% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nanalysis Scientific Corp right now?
The large discount to fair value meets weak quality (35/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.1816). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Nanalysis Scientific Corp

How large is the market capitalisation of Nanalysis Scientific Corp (NSCIF)?
The market capitalisation of Nanalysis Scientific Corp is $11.5M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nanalysis Scientific Corp (NSCIF)?
The price-to-sales ratio of Nanalysis Scientific Corp is 0.29 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nanalysis Scientific Corp (NSCIF)?
Earnings per share at Nanalysis Scientific Corp are $−0.0400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Nanalysis Scientific Corp (NSCIF)?
The net margin of Nanalysis Scientific Corp is −14.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nanalysis Scientific Corp (NSCIF)?
The return on equity (ROE) of Nanalysis Scientific Corp is −41.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nanalysis Scientific Corp (NSCIF)?
On an EBIT basis the return on assets of Nanalysis Scientific Corp is −12.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nanalysis Scientific Corp (NSCIF)?
The operating margin of Nanalysis Scientific Corp is −8.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nanalysis Scientific Corp (NSCIF)?
Revenue at Nanalysis Scientific Corp is growing +0.7% versus a year earlier (3y avg +17.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Nanalysis Scientific Corp (NSCIF) carry?
The net debt of Nanalysis Scientific Corp is C$15.4M (fiscal year 2025, ≈ 9.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Nanalysis Scientific Corp in the live analysis

One click puts Nanalysis Scientific Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.